Bruker Corporation
BRKR
$44.96
-$0.60-1.32%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 13.70M | 40.90M | 7.60M | 50.90M | 205.50M |
Total Depreciation and Amortization | 52.90M | 51.00M | 45.20M | 34.70M | 37.30M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 32.40M | -6.10M | 6.70M | -400.00K | -158.60M |
Change in Net Operating Assets | 91.00M | -47.40M | -58.40M | -63.40M | 121.30M |
Cash from Operations | 190.00M | 38.40M | 1.10M | 21.80M | 205.50M |
Capital Expenditure | -36.70M | -32.60M | -24.60M | -21.40M | -31.50M |
Sale of Property, Plant, and Equipment | 200.00K | 0.00 | 400.00K | 500.00K | 200.00K |
Cash Acquisitions | -22.90M | -200.00K | -1.30B | -274.50M | -4.30M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -1.20M | -34.80M | 1.30M | -8.80M | -1.20M |
Cash from Investing | -60.60M | -67.60M | -1.32B | -304.20M | -36.80M |
Total Debt Issued | 178.10M | 166.90M | 1.61B | 268.90M | -1.20M |
Total Debt Repaid | -231.70M | -158.30M | -850.40M | -107.70M | -5.20M |
Issuance of Common Stock | 3.20M | -- | 405.20M | 3.40M | 4.70M |
Repurchase of Common Stock | -- | -2.80M | -- | -- | -50.40M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -7.60M | -7.60M | -7.70M | -7.30M | -7.30M |
Other Financing Activities | -17.00M | -900.00K | -1.40M | -5.60M | -500.00K |
Cash from Financing | -75.00M | -2.70M | 1.16B | 151.70M | -59.90M |
Foreign Exchange rate Adjustments | -19.40M | 10.40M | -2.10M | -17.60M | 15.90M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 35.00M | -21.50M | -170.10M | -148.30M | 124.70M |